Structural and biosensor analyses of a synthetic biotinylated peptide probe for the isolation of adenomatous polyposis coli tumor suppressor protein complexes
Jd. Wade et al., Structural and biosensor analyses of a synthetic biotinylated peptide probe for the isolation of adenomatous polyposis coli tumor suppressor protein complexes, J PEPT RES, 58(3), 2001, pp. 204-212
Large numbers of colon tumors stem from mutations in the gene coding for th
e production of the adenomatous polyposis coli (APC) tumor suppressor prote
in. This protein contains a coiled-coil N-terminal domain that is known to
be responsible for homodimerization. Previous work by others has led to the
design of a specific 54-residue anti-APC peptide (anti-APCp(1)) that dimer
izes preferentially with this domain. We have undertaken the chemical synth
esis of a modified form of this peptide (anti-APCp(2)) that bears a biotin
moiety at its N-terminus for use in subsequent ligand-binding analysis stud
ies. The peptide was subjected to comprehensive chemical characterization t
o confirm its purity. Secondary structural analysis by circular dichroism s
pectroscopy and Fourier transform infrared spectroscopy indicated that the
peptide could assume a wide range of potential conformations, depending upo
n the precise microenvironment. Significantly, a stable chi -helical struct
ure was generated when the solvent conditions supported intramolecular salt
-bridge formation along the helix barrel. The biotinylated anti-APCp(2) was
immobilized onto a streptavidin sensor surface, in a specific orientation
leaving all amino acids available to form a coiled structure. In one experi
ment, injection of colonic cell lysate extracts (LlM1215) onto a size-exclu
sion column resulted in the isolation of a high molecular mass protein peak
(> 600 kDa) that reacted specifically with the. immobilized anti-APCp(2) o
n the biosensor surface. In another experiment, a high molecular mass prote
in (M-r> 250 kDa on SDS-PAGE) could be specifically immunoprecipitated from
this peak using either the anti-APCp(2) peptide or an anti-APC polyclonal
antibody. This demonstrates the specific interaction between the anti-APCp(
2) peptide and native APC and highlights the potential use of the former pe
ptide in a multidimensional micropreparative chromatographic/biosensor/prot
eomic protocol for the purification of APC alone and APC complexed with dif
ferent biopolymers in various cell lines, and stages of tumor development.